Fluorescence in situ hybridization (FISH) may accurately identify patients who obtain survival benefit from herceptin plus chemotherapy
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S261-S262
- https://doi.org/10.1016/s0959-8049(01)81462-3
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: